Skip to content

Wheezing Illnesses Study Leidsche Rijn/ Adolescents & Young Adults

Wheezing Illnesses Study Leidsche Rijn/ Adolescents & Young Adults - WHISTLER Adolescents

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54512
Enrollment
1000
Registered
2018-07-27
Start date
2019-03-12
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma and well-being of children in puberty, adolescents and young adults asthma and well-being of children in puberty, youngsters and young adults

Interventions

None

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
12 Years to 64 Years

Inclusion criteria

Inclusion criteria: Adolescents and young adults who reached the age of 12-24 years and who already participated in the  WHISTLER-0 and/or WHISTLER/Cardio and/or WHISTLER/Cardio2 study, and who's  parents and subject are willing to give informed consent to participate in this  study. From age 16, informed consent will be obtained from the adolescent only. Adolescents and young adults aged 12-24 years who already participated in the  WHISTLER round aged 12-16 years consisting of only online questionnaires,  because of the corona epidemic, will be included. This group, which consists of  around 300 children, will be approached for this new WHISTLER/ Adolescent & Young Adult round  since it consists of new physical measurements and an amended online  questionnaire.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Part 1: cIMT and PWV as cardiovascular outcomes. Part 2: lung function measurements (spirometry). Part 3: QoL, happiness, well-being and resilience will be measured using validated questionnaires. Part 4: different markers of disease activity defined through questionnaires, physical examination and markers in the blood, depending on the chronic disorder, will be examined in the WHISTLER population.

Secondary

MeasureTime frame
Part 1: Carotid artery distension using ultrasound. Endothelial functioning using flow mediated dilation. Dyslipidemia using a lipid panel including total cholesterol, total triglycerides, apolipoprotein B (ApoB), lipoprotein a (Lp(a)), HDL- and LDL-cholesterol and HbA1c. Inflammation using CRP levels. Intra-abdominal and subcutaneous fat measured by ultrasound. Part 2: Allergic sensitization patterns and specific IgE-profiling in the blood next to reported allergies by a questionnaire. Part 3: Biological stress marker hair cortisol.

Countries

Netherlands

Contacts

Public ContactD.E. Bruil

Universitair Medisch Centrum Utrecht

d.e.bruil@umcutrecht.nl+31 (0)6 50177830

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026